Metraipolis › archive › dc_c046ddece1e2

Pan-cancer analysis of TRPV1: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction — Europe PMC PMID:41535811

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41535811
DOI
10.1186/s12885-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-06T19:27:21.796Z
SHA-256 of the archived text
88c719f3ab3d551101005005e937a93cafe61c601eba5af76146fd6aed276e5b
Stable URL of this page
https://metraipolis.com/documento/dc_c046ddece1e2

How to cite

Pan-cancer analysis of TRPV1: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction — Europe PMC PMID:41535811 — Europe PMC (en), https://europepmc.org/article/MED/41535811 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c046ddece1e2 (Metraipolis archive dc_c046ddece1e2, sha256 88c719f3ab3d551101005005e937a93cafe61c601eba5af76146fd6aed276e5b)
BibTeX
@misc{dcc046ddece1e2,
  title = {Pan-cancer analysis of TRPV1: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction — Europe PMC PMID:41535811},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41535811},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c046ddece1e2; sha256 88c719f3ab3d551101005005e937a93cafe61c601eba5af76146fd6aed276e5b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41535811. Agents can read the archived copy with the MCP tool read_document.